Seeking men and women 18-75 years of age with a type of liver cancer called advanced hepatocellular carcinoma (HCC) for participation in a study of an investigational drug called CS1003, or a placebo, in combination with the standard treatment.
We are studying the effects of an investigational drug named CS1003 and its safety for patients with HCC.
What we're hoping for
To evaluate the how well CS1003 works, how safe it is, and how well it is tolerated in addition to the standard treatment for this type of cancer.
ClinicalTrials.gov Identifier: NCT04194775